Valacyclovir - CAS# 124832-26-4 a-Naloxol D5 Hydrochloride Smiles: CC(C)C[C@H](NC=O)C(=O)O[C@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)CCCCCCCCCCC

Smiles: CC(C)C[C@H](NC=O)C(=O)O[C@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)CCCCCCCCCCC

Smiles: O=C(NC1N=C2C=CC=C(C3C=CC(CN4CCS(=O)(=O)CC4)=CC=3)N2N=1)C1CC1

InChiKey: RUZYUOTYCVRMRZ-UHFFFAOYSA-N

Janus kinases (JAKs) are a family of cytoplasmic tyrosine kinases that mediates signals from the receptors for various cytokines and growth factors that have a key role in haematopoiesis and immune function

FC1C=CC(=CC=1)C(C1C=CC(F)=CC=1)N1CCN(C/C=C/C2C=CC=CC=2)CC1

Valacyclovir - CAS# 124832-26-4 a-Naloxol D5 Hydrochloride Smiles: CC(C)C[C@H](NC=O)C(=O)O[C@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)CCCCCCCCCCCValacyclovir, also known as valacyclovir, is an antiviral drug used in the management of herpes simplex, herpes zoster (shingles), and herpes B. It is a prodrug, being converted in vivo to aciclovir. Valaciclovir has been available as a generic drug in the U. S. since November 25, 2009. Valaciclovir is a prodrug, an esterified version of aciclovir that has greater oral bioavailability (about 55%) than aciclovir (1020%). It is converted by esterases to